NewLink Genetics Announces FDA Accepts Partnered Biologics License Application (BLA) and Grants Priority Review for Ebola Vaccine V920 (rVSV∆G-ZEBOV-GP)

Ads

You May Also Like

Biogen Enhances Commitment to SMA Research with Data Presented at Annual SMA Conference

Research includes clinical trial data across broad SMA patient populations, expanding scientific understanding of ...

Sunesis Pharmaceuticals Reports Third Quarter 2017 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...